Background Magnesium sulphate has been used in some settings as a tocolytic agent to
inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth …

Background Magnesium maintenance therapy is one of the types of tocolytic therapy used
after an episode of threatened preterm labour (usually treated with an initial dose of tocolytic …

Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

Background Antenatal magnesium sulphate, widely used in obstetrics to improve maternal
and infant outcomes, may be associated with adverse effects for the mother sufficient for …

Background Epidemiological and basic science evidence suggests that magnesium
sulphate before birth may be neuroprotective for the fetus. Objectives To assess the effects …

High-dosage, tocolytic magnesium sulfate (MgSO 4) administered to pregnant women
during preterm labor can be toxic, and sometimes lethal, for their newborns (Cochrane …

Background Babies born preterm are at an increased risk of dying in the first weeks of life,
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …

Objective: The purpose of this study was to determine whether the use of antenatal
magnesium sulfate prevents adverse outcomes (neonatal intraventricular hemorrhage …

Approximately half of the more than 500,000 preterm births each year result from preterm
labor. Tocolytic therapy continues to be the focus of treatment of these women. Although a …

Background Magnesium is an essential mineral required for regulation of body temperature,
nucleic acid and protein synthesis and in maintaining nerve and muscle cell electrical …